|
1
|
Schaff LR and Grommes C: Primary central
nervous system lymphoma. Blood. 140:971–979. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stock W: Adolescents and young adults with
acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ
Program. 2010:21–29. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hirakawa T, Yamaguchi H, Yokose N, Gomi S,
Inokuchi K and Dan K: Importance of maintaining the relative dose
intensity of CHOP-like regimens combined with rituximab in patients
with diffuse large B-cell lymphoma. Ann Hematol. 89:897–904. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bataillard EJ, Cheah CY, Maurer MJ,
Khurana A, Eyre TA and El-Galaly TC: Impact of R-CHOP dose
intensity on survival outcomes in diffuse large B-cell lymphoma: A
systematic review. Blood Adv. 5:2426–2437. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Farhi J, Laribi K, Orvain C, Hamel JF,
Mercier M, Galy AS, Clavert A, Rousselet MC, Tanguy-Schmidt A,
Hunault-Berger M and Moles-Moreau MP: Impact of front line relative
dose intensity for methotrexate and comorbidities in
immunocompetent elderly patients with primary central nervous
system lymphoma. Ann Hematol. 97:2391–2401. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferreri AJ, Blay JY, Reni M, Pasini F,
Spina M, Ambrosetti A, Calderoni A, Rossi A, Vavassori V, Conconi
A, et al: Prognostic scoring system for primary CNS lymphomas: The
international Extranodal lymphoma study group experience. J Clin
Oncol. 21:266–272. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Abrey LE, Ben-Porat L, Panageas KS,
Yahalom J, Berkey B, Curran W, Schultz C, Leibel S, Nelson D, Mehta
M and DeAngelis LM: Primary central nervous system lymphoma: The
Memorial Sloan-Kettering cancer center prognostic model. J Clin
Oncol. 24:5711–5715. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Morris PG, Correa DD, Yahalom J, Raizer
JJ, Schiff D, Grant B, Grimm S, Lai RK, Reiner AS, Panageas K, et
al: Rituximab, methotrexate, procarbazine, and vincristine followed
by consolidation reduced-dose whole-brain radiotherapy and
cytarabine in newly diagnosed primary CNS lymphoma: Final results
and long-term outcome. J Clin Oncol. 31:3971–3979. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abrey LE, Batchelor TT, Ferreri AJ,
Gospodarowicz M, Pulczynski EJ, Zucca E, Smith JR, Korfel A,
Soussain C, DeAngelis LM, et al: Report of an international
workshop to standardize baseline evaluation and response criteria
for primary CNS lymphoma. J Clin Oncol. 23:5034–5043. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hiroi T, Hosoi H, Kuriyama K, Murata S,
Morimoto M, Mushino T, Nishikawa A, Tamura S and Sonoki T: An
evaluation based on relative treatment intensity in older patients
treated with reduced-dose R-THP-COP therapy for diffuse large
B-cell lymphoma: A multicenter retrospective cohort study. J
Geriatr Oncol. 14:1013962023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kondo E, Ikeda T, Goto H, Nishikori M,
Maeda N, Matsumoto K, Kitagawa H, Noda N, Sugimoto S and Hara J:
Pharmacokinetics of thiotepa in high-dose regimens for autologous
hematopoietic stem cell transplant in Japanese patients with
pediatric tumors or adult lymphoma. Cancer Chemother Pharmacol.
84:849–860. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okamura T, Hosoi H, Matsufusa T, Akagi Y,
Iwamoto R, Kosako H, Murata S, Mushino T, Murata SI and Sonoki T:
Tirabrutinib maintenance therapy for a patient with high-dose
methotrexate-ineligible primary central nervous system lymphoma.
Ann Hematol. 101:1379–1381. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boissel N, Auclerc MF, Lheritier V, Perel
Y, Thomas X, Leblanc T, Rousselot P, Cayuela JM, Gabert J, Fegueux
N, et al: Should adolescents with acute lymphoblastic leukemia be
treated as old children or young adults? Comparison of the French
FRALLE-93 and LALA-94 trials. J Clin Oncol. 21:774–780. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stock W, La M, Sanford B, Bloomfield CD,
Vardiman JW, Gaynon P, Larson RA and Nachman J; Children's Cancer
Group, : Cancer and Leukemia Group B studies: What determines the
outcomes for adolescents and young adults with acute lymphoblastic
leukemia treated on cooperative group protocols? A comparison of
children's cancer group and cancer and leukemia group B studies.
Blood. 112:1646–1654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schiffer CA: Differences in outcome in
adolescents with acute lymphoblastic leukemia: A consequence of
better regimens? Better doctors? Both? J Clin Oncol. 21:760–761.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lepage E, Gisselbrecht C, Haioun C, Sebban
C, Tilly H, Bosly A, Morel P, Herbrecht R, Reyes F and Coiffier B:
Prognostic significance of received relative dose intensity in
non-Hodgkin's lymphoma patients: Application to LNH-87 protocol.
The GELA (Groupe d'Etude des Lymphomes de l'Adulte). Ann Oncol.
4:651–656. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ferreri AJ, Cwynarski K, Pulczynski E,
Ponzoni M, Deckert M, Politi LS, Torri V, Fox CP, Rosée PL, Schorb
E, et al: Chemoimmunotherapy with methotrexate, cytarabine,
thiotepa, and rituximab (MATRix regimen) in patients with primary
CNS lymphoma: Results of the first randomisation of the
international Extranodal lymphoma study group-32 (IELSG32) phase 2
trial. Lancet Haematol. 3:e217–227. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kasenda B, Ferreri AJ, Marturano E, Forst
D, Bromberg J, Ghesquieres H, Ferlay C, Blay JY, Hoang-Xuan K,
Pulczynski EJ, et al: First-line treatment and outcome of elderly
patients with primary central nervous system lymphoma (PCNSL)-a
systematic review and individual patient data meta-analysis. Ann
Oncol. 26:1305–1313. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hoang-Xuan K, Bessell E, Bromberg J,
Hottinger AF, Preusser M, Rudà R, Schlegel U, Siegal T, Soussain C,
Abacioglu U, et al: Diagnosis and treatment of primary CNS lymphoma
in immunocompetent patients: Guidelines from the European
association for neuro-oncology. Lancet Oncol. 16:e322–332. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ferreri AJM, Cwynarski K, Pulczynski E,
Fox CP, Schorb E, La Rosée P, Binder M, Fabbri A, Torri V,
Minacapelli E, et al: Whole-brain radiotherapy or autologous
stem-cell transplantation as consolidation strategies after
high-dose methotrexate-based chemoimmunotherapy in patients with
primary CNS lymphoma: Results of the second randomisation of the
international Extranodal lymphoma study group-32 phase 2 trial.
Lancet Haematol. 4:e510–e523. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Houillier C, Taillandier L, Dureau S, Lamy
T, Laadhari M, Chinot O, Moluçon-Chabrot C, Soubeyran P, Gressin R,
Choquet S, et al: Radiotherapy or autologous stem-cell
transplantation for primary CNS lymphoma in patients 60 years of
age and younger: Results of the intergroup ANOCEF-GOELAMS
randomized phase II PRECIS study. J Clin Oncol. 37:823–833. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sasaki N, Kobayashi K, Saito K, Shimizu S,
Suzuki K, Lee J, Yamagishi Y, Shibahara J, Takayama N, Shiokawa Y
and Nagane M: Consecutive single-institution case series of primary
central nervous system lymphoma treated by R-MPV or high-dose
methotrexate monotherapy. Jpn J Clin Oncol. 50:999–1008. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Patel AM, Ali O, Kainthla R, Rizvi SM,
Awan FT, Patel T, Pan E, Maher E, Desai NB, Timmerman R, et al:
Primary central nervous system lymphoma: A real-world comparison of
therapy access and outcomes by hospital setting. Neurooncol Pract.
9:183–192. 2022.PubMed/NCBI
|
|
25
|
Calimeri T, Steffanoni S, Gagliardi F,
Chiara A and Ferreri AJM: How we treat primary central nervous
system lymphoma. ESMO Open. 6:1002132021. View Article : Google Scholar : PubMed/NCBI
|
